Genmab A/S: Genmab Announces Multiple Abstracts to be Presented at the 63rd Annual Meeting and Exposition of the American Society of Hematology (ASH)
Poster presentations highlighting safety and preliminary efficacy data of epcoritamab (DuoBody-CD3xCD20) in combination with other treatments in patients with B-cell non-Hodgkin lymphoma (NHL)
United States New Jersey Marisol Peron Genmab Duobody Andrew Carlsen Exposition Of The American Society Hematology
Source: finanznachrichten.de